These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8956919)

  • 21. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
    French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V;
    Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group.
    Biton V; Montouris GD; Ritter F; Riviello JJ; Reife R; Lim P; Pledger G
    Neurology; 1999 Apr; 52(7):1330-7. PubMed ID: 10227614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
    French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
    Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
    Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
    Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults.
    Reife R; Pledger G; Wu SC
    Epilepsia; 2000; 41(S1):66-71. PubMed ID: 10768304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD; Hulihan J; Karim MR; Wu SC; Jordan D; Karvois D; Kamin M
    Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group.
    Sachdeo RC; Glauser TA; Ritter F; Reife R; Lim P; Pledger G
    Neurology; 1999 Jun; 52(9):1882-7. PubMed ID: 10371538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
    Majkowski J; Neto W; Wapenaar R; Van Oene J
    Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Topiramate (Topamax). Pharmacological characteristics and current use in epilepsy treatment].
    Bauer J; Schwalen S
    Nervenarzt; 2000 Jun; 71(6):495-501. PubMed ID: 10919147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
    Gilliam FG; Veloso F; Bomhof MA; Gazda SK; Biton V; Ter Bruggen JP; Neto W; Bailey C; Pledger G; Wu SC
    Neurology; 2003 Jan; 60(2):196-202. PubMed ID: 12552030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
    Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
    Abou-Khalil B
    Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group.
    Ritter F; Glauser TA; Elterman RD; Wyllie E
    Epilepsia; 2000; 41(S1):82-5. PubMed ID: 10768307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
    JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate: New preparation. Helpful in refractory partial epilepsy.
    Prescrire Int; 1999 Feb; 8(39):3-5. PubMed ID: 10557563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate: a new antiepileptic drug.
    Privitera MD
    Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
    Storey JR; Calder CS; Hart DE; Potter DL
    Headache; 2001; 41(10):968-75. PubMed ID: 11903524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.